
zzso zzso zzso zzso is a low molecular weight, zzso analog zzso cellular DNA zzso Currently, it is the frontline drug approved by Food and Drug Administration zzso for the treatment of pancreatic zzso However, efforts to use zzso as an zzso agent have been limited by its short circulation time and rapid metabolism that reflects in low tumor zzso and zzso zzso zzso zzso in this regard have spawned an approach to improve the zzso efficiency and zzso of zzso by chemical zzso The present study describes the synthesis of a water soluble zzso of zzso zzso characterized by zzso zzso zzso zzso and zzso zzso The zzso zzso has a prolonged circulation time in plasma as studied in an animal zzso This eventually caused a marked improvement in the zzso and zzso activity in pancreatic cancer cell lines zzso zzso 2 and zzso zzso zzso these findings demonstrate the zzso zzso is a desirable approach for therapy by intravenous zzso zzso clinical application of this approach can significantly contribute to the treatment of pancreatic zzso 

